In Response to 'Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer: Are We There Yet?'
Keywords: Drug Therapy, gemcitabine, Neoplasm Metastasis, Pancreatic Neoplasms
No abstract available.
Image: Addenbrooke’s Hospital. Cambridge, United Kingdom.
Download data is not yet available.
Gounaris I, Zaki K, Corrie P. Options for the treatment of gemcitabine-resistant advanced pancreatic cancer. JOP. J Pancreas (Online) 2010; 11:113-23. [PMID 20208317] (FULLTEXT: http://www.joplink.net/prev/201003/09.html)
How to Cite
GounarisI., ZakiK., & CorrieP. (2010). In Response to ’Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer: Are We There Yet?’. JOP. Journal of the Pancreas, 11(3), 290. https://doi.org/10.6092/1590-8577/3835
Copyright (c) 2010 Ioannis Gounaris, Kamarul Zaki, Pippa Corrie
This work is licensed under a Creative Commons Attribution 4.0 International License.As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.